4.2(top 10%)
2-year impact
27.4K(top 1%)
PR articles
673.2K(top 1%)
PR citations
284(top 1%)
PR h-index
313(top 1%)
h-index
4.1(top 10%)
2-YI (no self-cite.)
29.6K
documents
860.5K
doc citations

Top Articles

#TitleJournalYearCitations
1EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology20186,206
2EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology20124,083
3Histological grading and staging of chronic hepatitisJournal of Hepatology19954,024
4EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infectionJournal of Hepatology20173,876
5EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseJournal of Hepatology20163,224
6A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJournal of Hepatology20203,158
7BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateJournal of Hepatology20222,971
8Burden of liver diseases in the worldJournal of Hepatology20192,607
9Expanding consensus in portal hypertensionJournal of Hepatology20152,234
10Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesJournal of Hepatology20062,173
11EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infectionJournal of Hepatology20122,154
12EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosisJournal of Hepatology20181,993
13Baveno VII – Renewing consensus in portal hypertensionJournal of Hepatology20221,962
14The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology20061,735
15The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysisJournal of Hepatology20191,616
16The gut-liver axis in liver disease: Pathophysiological basis for therapyJournal of Hepatology20201,613
17Non-alcoholic fatty liver disease – A global public health perspectiveJournal of Hepatology20191,582
18Global burden of primary liver cancer in 2020 and predictions to 2040Journal of Hepatology20221,557
19Global burden of liver disease: 2023 updateJournal of Hepatology20231,557
20Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030Journal of Hepatology20181,413
21EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 updateJournal of Hepatology20211,340
22EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisJournal of Hepatology20151,326
23Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver diseaseJournal of Hepatology20151,286
24Classification of chronic viral hepatitis: a need for reassessmentJournal of Hepatology19911,271
25EASL Clinical Practice Guidelines: Management of chronic hepatitis BJournal of Hepatology20091,266
26EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Journal of Hepatology20241,232
27EASL Clinical Practice Guidelines: Management of cholestatic liver diseasesJournal of Hepatology20091,216
28EASL Recommendations on Treatment of Hepatitis C 2018Journal of Hepatology20181,205
29Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology20101,170
30EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosisJournal of Hepatology20101,155
31Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinomaJournal of Hepatology20221,154
32Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomyJournal of Hepatology20031,109
33Guidelines for the diagnosis and management of intrahepatic cholangiocarcinomaJournal of Hepatology20141,073
34EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitisJournal of Hepatology20171,063
35Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysisJournal of Hepatology2016993
36Treatment of NAFLD with diet, physical activity and exerciseJournal of Hepatology2017963
37Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosisJournal of Hepatology2017934
38Endoplasmic reticulum stress in liver diseaseJournal of Hepatology2011918
39Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factorsJournal of Hepatology2008895
40EASL Clinical Practice Guidelines: Autoimmune hepatitisJournal of Hepatology2015895
41NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in miceJournal of Hepatology2017884
42Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevanceJournal of Hepatology2014871
43The burden of liver disease in Europe: A review of available epidemiological dataJournal of Hepatology2013853
44EASL recommendations on treatment of hepatitis C: Final update of the series☆Journal of Hepatology2020851
45Criteria of drug-induced liver disordersJournal of Hepatology1990843
46Macrophage heterogeneity in liver injury and fibrosisJournal of Hepatology2014830
47EASL Recommendations on Treatment of Hepatitis C 2015Journal of Hepatology2015830
48Altered profile of human gut microbiome is associated with cirrhosis and its complicationsJournal of Hepatology2014827
49Complications following percutaneous liver biopsyJournal of Hepatology1986825
50EASL Clinical Practice Guidelines: Wilson’s diseaseJournal of Hepatology2012823